BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ektate K, Munteanu MC, Ashar H, Malayer J, Ranjan A. Chemo-immunotherapy of colon cancer with focused ultrasound and Salmonella-laden temperature sensitive liposomes (thermobots). Sci Rep 2018;8:13062. [PMID: 30166607 DOI: 10.1038/s41598-018-30106-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Yang R, Shen J, Huang Q, Wu Z. Research Progress of Bioinspired Nanostructured Systems for the Treatment of Ocular Disorders. Pharmaceuticals (Basel) 2023;16. [PMID: 36678597 DOI: 10.3390/ph16010096] [Reference Citation Analysis]
2 Namakshenas P, Mojra A. Efficient drug delivery to hypoxic tumors using thermosensitive liposomes with encapsulated anti-cancer drug under high intensity pulsed ultrasound. International Journal of Mechanical Sciences 2023;237:107818. [DOI: 10.1016/j.ijmecsci.2022.107818] [Reference Citation Analysis]
3 Swetha KL, Maravajjala KS, Li SD, Singh MS, Roy A. Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation. Drug Deliv Transl Res 2023;13:105-34. [PMID: 35697894 DOI: 10.1007/s13346-022-01194-7] [Reference Citation Analysis]
4 Chen WC, Hsu CC, Huang HJ, Cheng WJ, Chang TC, Chou HH. Letrozole as premedication of high intensity focused ultrasound treatment of uterine fibroids: A retrospective observation study. Front Med (Lausanne) 2022;9:1069654. [PMID: 36561715 DOI: 10.3389/fmed.2022.1069654] [Reference Citation Analysis]
5 Ghosh P, Tiwari H, Lakkakula J, Roy A, Emran TB, Rashid S, Alghamdi S, Rajab BS, Almehmadi M, Allahyani M, Aljuaid A, Alsaiari AA, Sharma R, Babalghith AO. A decade's worth of impact: Dox loaded liposomes in anticancer activity. Materials Today Advances 2022;16:100313. [DOI: 10.1016/j.mtadv.2022.100313] [Reference Citation Analysis]
6 Hashemi M, Ghadyani F, Hasani S, Olyaee Y, Raei B, Khodadadi M, Ziyarani MF, Basti FA, Tavakolpournegari A, Matinahmadi A, Salimimoghadam S, Aref AR, Taheriazam A, Entezari M, Ertas YN. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104112] [Reference Citation Analysis]
7 Liang S, Wang C, Shao Y, Wang Y, Xing D, Geng Z. Recent advances in bacteria-mediated cancer therapy. Front Bioeng Biotechnol 2022;10:1026248. [DOI: 10.3389/fbioe.2022.1026248] [Reference Citation Analysis]
8 Dai Q, Cao B, Zhao S, Zhang A. Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future. Bioengineering 2022;9:474. [DOI: 10.3390/bioengineering9090474] [Reference Citation Analysis]
9 Becerra-báez EI, Meza-toledo SE, Muñoz-lópez P, Flores-martínez LF, Fraga-pérez K, Magaño-bocanegra KJ, Juárez-hernández U, Mateos-chávez AA, Luria-pérez R. Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy. Cancers 2022;14:4224. [DOI: 10.3390/cancers14174224] [Reference Citation Analysis]
10 Feng J, Liu Y, Pan X, Jin F, Wu L, Chen J, Wan B, Zhang X, Rodrigues LR, Zhang Y. Acid-Directed Electrostatic Self-Assembly Generates Charge-Reversible Bacteria for Enhanced Tumor Targeting and Low Tissue Trapping. ACS Appl Mater Interfaces 2022. [PMID: 35917371 DOI: 10.1021/acsami.2c08684] [Reference Citation Analysis]
11 Li S, Yue H, Wang S, Li X, Wang X, Guo P, Ma G, Wei W. Advances of bacteria-based delivery systems for modulating tumor microenvironment. Adv Drug Deliv Rev 2022;188:114444. [PMID: 35817215 DOI: 10.1016/j.addr.2022.114444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tang Q, Peng X, Xu B, Zhou X, Chen J, Cheng L. Current Status and Future Directions of Bacteria-Based Immunotherapy. Front Immunol 2022;13:911783. [PMID: 35757741 DOI: 10.3389/fimmu.2022.911783] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen W, Zhu Y, Zhang Z, Sun X. Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy. Adv Drug Deliv Rev 2022;185:114295. [PMID: 35429576 DOI: 10.1016/j.addr.2022.114295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Sheoran S, Arora S, Samsonraj R, Govindaiah P, vuree S. Lipid-based nanoparticles for treatment of cancer. Heliyon 2022;8:e09403. [DOI: 10.1016/j.heliyon.2022.e09403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kang Z, Yang M, Feng X, Liao H, Zhang Z, Du Y. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell. IJN 2022;Volume 17:2165-87. [DOI: 10.2147/ijn.s360161] [Reference Citation Analysis]
16 Bao Y, Cheng Y, Liu W, Luo W, Zhou P, Qian D. Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology. Front Oncol 2022;12:845346. [DOI: 10.3389/fonc.2022.845346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Moreno VM, Baeza A. Bacteria as Nanoparticle Carriers for Immunotherapy in Oncology. Pharmaceutics 2022;14:784. [DOI: 10.3390/pharmaceutics14040784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li D, Liu Z, Ding X, Qin Z. AEBP1 Is One of the Epithelial-Mesenchymal Transition Regulatory Genes in Colon Adenocarcinoma. Biomed Res Int 2021;2021:3108933. [PMID: 34938806 DOI: 10.1155/2021/3108933] [Reference Citation Analysis]
19 Allemailem KS. Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management. Int J Nanomedicine 2021;16:8159-84. [PMID: 34938075 DOI: 10.2147/IJN.S338272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Yin T, Diao Z, Blum NT, Qiu L, Ma A, Huang P. Engineering Bacteria and Bionic Bacterial Derivatives with Nanoparticles for Cancer Therapy. Small 2021;:e2104643. [PMID: 34908239 DOI: 10.1002/smll.202104643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
21 Rix A, Girbig R, Porte C, Lederle W, Leenaars C, Kiessling F. Development of a Systematic Review Protocol and a Scoping Review of Ultrasound-Induced Immune Effects in Peripheral Tumors. Mol Imaging Biol 2021. [PMID: 34845660 DOI: 10.1007/s11307-021-01686-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Moghimipour E, Abedishirehjin S, Baghbadorani MA, Handali S. Bacteria and Archaea: A new era of cancer therapy. J Control Release 2021;338:1-7. [PMID: 34391833 DOI: 10.1016/j.jconrel.2021.08.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ranjan A, Kishore D, Ashar H, Neel T, Singh A, More S. Focused ultrasound ablation of a large canine oral tumor achieves efficient tumor remission: a case report. Int J Hyperthermia 2021;38:552-60. [PMID: 33784931 DOI: 10.1080/02656736.2021.1903582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Gorbet MJ, Singh A, Mao C, Fiering S, Ranjan A. Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits. Int J Hyperthermia 2020;37:18-33. [PMID: 33426995 DOI: 10.1080/02656736.2020.1802519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Chen C, Wang Y, Tang Y, Wang L, Jiang F, Luo Y, Gao X, Li P, Zou J. Bifidobacterium-mediated high-intensity focused ultrasound for solid tumor therapy: comparison of two nanoparticle delivery methods. Int J Hyperthermia 2020;37:870-8. [PMID: 32689830 DOI: 10.1080/02656736.2020.1791365] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Mughal MJ, Kwok HF. Multidimensional role of bacteria in cancer: Mechanisms insight, diagnostic, preventive and therapeutic potential. Semin Cancer Biol 2021:S1044-579X(21)00181-4. [PMID: 34119644 DOI: 10.1016/j.semcancer.2021.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Hani U, Honnavalli YK, Begum MY, Yasmin S, Osmani RAM, Ansari MY. Colorectal cancer: A comprehensive review based on the novel drug delivery systems approach and its management. Journal of Drug Delivery Science and Technology 2021;63:102532. [DOI: 10.1016/j.jddst.2021.102532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Ma G, Kostevšek N, Monaco I, Ruiz A, Markelc B, Cheung CCL, Hudoklin S, Kreft ME, Hassan HAFM, Barker M, Conyard J, Hall C, Meech S, Mayes AG, Serša I, Čemažar M, Marković K, Ščančar J, Franchini MC, Al-Jamal WT. PD1 blockade potentiates the therapeutic efficacy of photothermally-activated and MRI-guided low temperature-sensitive magnetoliposomes. J Control Release 2021;332:419-33. [PMID: 33677010 DOI: 10.1016/j.jconrel.2021.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Wang T, Suita Y, Miriyala S, Dean J, Tapinos N, Shen J. Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy. Pharmaceutics 2021;13:520. [PMID: 33918635 DOI: 10.3390/pharmaceutics13040520] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
30 Joiner JB, Pylayeva-Gupta Y, Dayton PA. Focused Ultrasound for Immunomodulation of the Tumor Microenvironment. J Immunol 2020;205:2327-41. [PMID: 33077668 DOI: 10.4049/jimmunol.1901430] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
31 Ye S, Sun B, Wu W, Yu C, Tian T, Lian Z, Liang Q, Zhou Y. LINC01123 facilitates proliferation, invasion and chemoresistance of colon cancer cells. Biosci Rep 2020;40:BSR20194062. [PMID: 32700743 DOI: 10.1042/BSR20194062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
32 Madamsetty VS, Mukherjee A, Paul M. Bioinspired nanoparticles-based drug delivery systems for cancer theranostics. Biogenic Nanoparticles for Cancer Theranostics 2021. [DOI: 10.1016/b978-0-12-821467-1.00008-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Shrivastava P, Sharma R, Gautam L, Vyas S, P. Vyas S. Nanoparticles and colon cancer. Nano Drug Delivery Strategies for the Treatment of Cancers 2021. [DOI: 10.1016/b978-0-12-819793-6.00009-6] [Reference Citation Analysis]
34 Guyon L, Groo AC, Malzert-Fréon A. Relevant Physicochemical Methods to Functionalize, Purify, and Characterize Surface-Decorated Lipid-Based Nanocarriers. Mol Pharm 2021;18:44-64. [PMID: 33244972 DOI: 10.1021/acs.molpharmaceut.0c00857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Cao Z, Liu J. Bacteria and bacterial derivatives as drug carriers for cancer therapy. J Control Release 2020;326:396-407. [PMID: 32681947 DOI: 10.1016/j.jconrel.2020.07.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
36 Wang Y, Chen C, Luo Y, Xiong J, Tang Y, Yang H, Wang L, Jiang F, Gao X, Xu D, Li H, Wang Q, Zou J. Experimental Study of Tumor Therapy Mediated by Multimodal Imaging Based on a Biological Targeting Synergistic Agent. Int J Nanomedicine 2020;15:1871-88. [PMID: 32256065 DOI: 10.2147/IJN.S238398] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
37 Bhargava A, Mishra DK, Tiwari R, Lohiya NK, Goryacheva IY, Mishra PK. Immune cell engineering: opportunities in lung cancer therapeutics. Drug Deliv Transl Res 2020;10:1203-27. [PMID: 32172351 DOI: 10.1007/s13346-020-00719-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Sethuraman SN, Singh MP, Patil G, Li S, Fiering S, Hoopes PJ, Guha C, Malayer J, Ranjan A. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity. Theranostics 2020;10:3397-412. [PMID: 32206098 DOI: 10.7150/thno.42243] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
39 Broadway KM, Scharf BE. Salmonella Typhimurium as an Anticancer Therapy: Recent Advances and Perspectives. Curr Clin Micro Rpt 2019;6:225-39. [DOI: 10.1007/s40588-019-00132-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
40 García-Pinel B, Porras-Alcalá C, Ortega-Rodríguez A, Sarabia F, Prados J, Melguizo C, López-Romero JM. Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment. Nanomaterials (Basel) 2019;9:E638. [PMID: 31010180 DOI: 10.3390/nano9040638] [Cited by in Crossref: 163] [Cited by in F6Publishing: 172] [Article Influence: 40.8] [Reference Citation Analysis]
41 Sang W, Zhang Z, Dai Y, Chen X. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. Chem Soc Rev 2019;48:3771-810. [DOI: 10.1039/c8cs00896e] [Cited by in Crossref: 195] [Cited by in F6Publishing: 208] [Article Influence: 48.8] [Reference Citation Analysis]